Covaxin for children above 2 years to be available by September

Covaxin for children above 2 years to be available by September: AIIMS Chief

Covaxin is expected to be available for children by September, says AIIMS Chief, Dr Randeep Guleria. According to an interview with India today, he said that "covaxin data for children after completion of phase 2/3 trials will be available by September and the approval is expected the same month. He added that if the Pfizer-BioNTech's  vaccine receives approval in India then that can also be one of the options for children." Whereas on 7 th June, AIIMS Delhi started vaccine clinical trials on kids between the age of 2years  to 17years. Meanwhile, the Drugs Controller General of India (DCGI )has granted permission on may to Bharat Biotech to commence phase 2-3 trials of Covaxin on children as young as two.

According to the statement given by AIIMS chief to PTI it also emphasized the third wave and he stated that "If Covid-19 appropriate behaviour is not followed, the third wave can happen in six to eight weeks. We need to work aggressively to prevent another large wave of vaccination kicks in." said the Chief.

Meanwhile, according to the report by ANI, on Tuesday, the subject expert committee (SEC) accepted and approved the phase 3 trial data of covaxin which showed 77.8% efficiency, said the report.